BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 24429406)

  • 1. The immune phenotype may relate to cancer development in kidney transplant recipients.
    Hope CM; Grace BS; Pilkington KR; Coates PT; Bergmann IP; Carroll RP
    Kidney Int; 2014 Jul; 86(1):175-83. PubMed ID: 24429406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune phenotype of peripheral blood cells and skin squamous cell carcinoma in organ transplant recipients.
    Dziunycz P; Hofbauer GF
    Expert Rev Clin Immunol; 2010 May; 6(3):359-62. PubMed ID: 20441422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretransplant Recipient Circulating CD4+CD127lo/- Tumor Necrosis Factor Receptor 2+ Regulatory T Cells: A Surrogate of Regulatory T Cell-Suppressive Function and Predictor of Delayed and Slow Graft Function After Kidney Transplantation.
    Nguyen MT; Fryml E; Sahakian SK; Liu S; Cantarovich M; Lipman M; Tchervenkov JI; Paraskevas S
    Transplantation; 2016 Feb; 100(2):314-24. PubMed ID: 26425877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effector Antitumor and Regulatory T Cell Responses Influence the Development of Nonmelanoma Skin Cancer in Kidney Transplant Patients.
    Crespo E; Fernandez L; Lúcia M; Melilli E; Lauzurica R; Penin RM; Quer A; Luque S; Quero M; Manonelles A; Torras J; Cruzado JM; Cañas L; Grinyó JM; Bestard O
    Transplantation; 2017 Sep; 101(9):2102-2110. PubMed ID: 28403126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Foxp3+ T cells in peripheral blood of renal transplant recipients and clinical correlations.
    Lin WX; Christiansen D; Fu LL; Roberts MA; Sandrin MS; Ierino FL
    Nephrology (Carlton); 2012 May; 17(4):415-22. PubMed ID: 22308996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation between skin cancer and HLA antigens in renal-transplant recipients.
    Bouwes Bavinck JN; Vermeer BJ; van der Woude FJ; Vandenbroucke JP; Schreuder GM; Thorogood J; Persijn GG; Claas FH
    N Engl J Med; 1991 Sep; 325(12):843-8. PubMed ID: 1875968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conversion to sirolimus in kidney transplant recipients with squamous cell cancer and changes in immune phenotype.
    Carroll RP; Hester J; Wood KJ; Harden PN
    Nephrol Dial Transplant; 2013 Feb; 28(2):462-5. PubMed ID: 23223314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kidney transplant recipients show an increase in the ratio of T-cell effector memory/central memory as compared to nontransplant recipients on the waiting list.
    Segundo DS; Fernández-Fresnedo G; Gago M; Beares I; Ruiz-Criado J; González M; Ruiz JC; Gómez-Alamillo C; López-Hoyos M; Arias M
    Transplant Proc; 2010 Oct; 42(8):2877-9. PubMed ID: 20970557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppression affects CD4+ mRNA expression and induces Th2 dominance in the microenvironment of cutaneous squamous cell carcinoma in organ transplant recipients.
    Kosmidis M; Dziunycz P; Suárez-Fariñas M; Mühleisen B; Schärer L; Läuchli S; Hafner J; French LE; Schmidt-Weber C; Carucci JA; Hofbauer GF
    J Immunother; 2010 Jun; 33(5):538-46. PubMed ID: 20463594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sun habits in kidney transplant recipients with skin cancer: a case-control study of possible causative factors.
    Lindelöf B; Granath F; Dal H; Brandberg Y; Adami J; Ullén H
    Acta Derm Venereol; 2003; 83(3):189-93. PubMed ID: 12816154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin lesions in adult liver transplant recipients: a study of 100 consecutive patients.
    Perera GK; Child FJ; Heaton N; O'Grady J; Higgins EM
    Br J Dermatol; 2006 May; 154(5):868-72. PubMed ID: 16634888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonmelanoma skin cancer after kidney transplant.
    Tepeoğlu M; Ayva Ş; Ok Atılgan A; Tunca MZ; Özdemir BH; Moray G; Yıldırım S; Arslan G; Haberal M
    Exp Clin Transplant; 2014 Jun; 12(3):233-7. PubMed ID: 24907724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory T cells, interleukin (IL)-6, IL-8, vascular endothelial growth factor (VEGF), CXCL10, CXCL11, epidermal growth factor (EGF) and hepatocyte growth factor (HGF) as surrogate markers of host immunity in patients with renal cell carcinoma.
    Polimeno M; Napolitano M; Costantini S; Portella L; Esposito A; Capone F; Guerriero E; Trotta A; Zanotta S; Pucci L; Longo N; Perdonà S; Pignata S; Castello G; Scala S
    BJU Int; 2013 Sep; 112(5):686-96. PubMed ID: 23495770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intense Foxp3+ CD25+ regulatory T-cell infiltration is associated with high-grade cutaneous squamous cell carcinoma and counterbalanced by CD8+/Foxp3+ CD25+ ratio.
    Azzimonti B; Zavattaro E; Provasi M; Vidali M; Conca A; Catalano E; Rimondini L; Colombo E; Valente G
    Br J Dermatol; 2015 Jan; 172(1):64-73. PubMed ID: 24910265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No association between infections, HLA type and other transplant-related factors and risk of cutaneous squamous cell carcinoma in solid organ transplant recipients.
    Ingvar Å; Ekström Smedby K; Lindelöf B; Fernberg P; Bellocco R; Tufveson G; Höglund P; Adami J
    Acta Derm Venereol; 2012 Nov; 92(6):609-14. PubMed ID: 22293782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoplastic skin lesions in Iranian renal transplant recipients: the role of immunosuppressive therapy.
    Zamanian A; Farshchian M
    J Drugs Dermatol; 2007 Jul; 6(7):703-6. PubMed ID: 17763593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for non-melanoma skin cancer in kidney transplant patients in a Spanish population in the Mediterranean region.
    Bernat García J; Morales Suárez-Varela M; Vilata JJ; Marquina A; Pallardó L; Crespo J
    Acta Derm Venereol; 2013 Jul; 93(4):422-7. PubMed ID: 23303600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008--a Swedish population-based study.
    Krynitz B; Edgren G; Lindelöf B; Baecklund E; Brattström C; Wilczek H; Smedby KE
    Int J Cancer; 2013 Mar; 132(6):1429-38. PubMed ID: 22886725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural Killer Lymphocytes Are Dysfunctional in Kidney Transplant Recipients on Diagnosis of Cancer.
    Peraldi MN; Berrou J; Venot M; Chardiny V; Durrbach A; Vieillard V; Debré P; Charron D; Suberbielle C; Chevret S; Glotz D; Dulphy N; Toubert A
    Transplantation; 2015 Nov; 99(11):2422-30. PubMed ID: 26798861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunophenotyping of peripheral immunoregulatory as well as Th17A and Th22 cell subpopulations in kidney transplant recipients under belatacept or cyclosporine treatment.
    Furuzawa-Carballeda J; Bostock IC; Lima G; Mancilla-Urrea E; Mondragón G; Reyes-Acevedo R; Chevaile A; Morales-Buenrostro LE; Llorente L; Alberú J
    Transpl Immunol; 2014 Mar; 30(2-3):107-13. PubMed ID: 24561014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.